Verse Medical
$53.0M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Verse Medical is currently valued at $772.0M as of June 10, 2025. The company has raised a total of $108.1M in funding.
Capital Efficiency
With a capital efficiency ratio of 7.14x, Verse Medical has achieved a valuation that is 7.14 times the total capital raised. This metric indicates strong capital efficiency and effective deployment of investor funds.
Investment Perspective
Verse Medical's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Verse Medical Worth in 2025?
As of 2025, Verse Medical is valued at $772.0M, based on the company's Later Stage VC funding round in June 10, 2025. This valuation positions Verse Medical as one of the leading private companies in the sector.
Verse Medical Valuation History
Verse Medical's funding history demonstrates steady growth and investor confidence.
How Verse Medical Valuation is Determined
Private company valuations like Verse Medical's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Verse Medical Valuation FAQs
Is Verse Medical profitable?
Verse Medical has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Verse Medical's valuation compare to competitors?
Verse Medical is valued at $772.0M, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Verse Medical IPO?
Verse Medical has not announced plans for an initial public offering. Until an IPO, investors can access Verse Medical shares through secondary market platforms.